The Myriad BRCA gene patent wars are continuing, and a new entrant has started a new fray by suing Myriad in a declaratory judgment suit. The Genomics Law Report provides a cogent summary.
top of page
The Intersection Among Torts, Science, Corporate Law, Insurance & Bankruptcy
GlobalTort
Search
Recent Posts
See All“Patent think” continues to retrench and retrace after SCOTUS’ series of unanimous rulings that ended patents for discovery of laws of...
John Oliver has now covered patent trolls. The world continues to change.
Patent litigation is dropping, but remains a significant sector in the litigation industry. Links to patent litigation statistics are...
bottom of page
Comments